Pathology Devices Market Size (2024 - 2029)

The Pathology Devices Market is projected to experience growth over the forecast period, driven by the increasing demand for advanced diagnostic tests due to the rising prevalence of chronic and infectious diseases. The market's expansion is supported by the development of innovative pathological test kits and devices, which have gained prominence following the increased demand during the COVID-19 pandemic. Despite these growth drivers, challenges such as high device costs, stringent regulations, and a shortage of skilled professionals may hinder market expansion.

Market Size of Pathology Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Pathology Devices Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 6.18 Billion
Market Size (2029) USD 8.32 Billion
CAGR (2024 - 2029) 6.12 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Pathology Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Pathology Devices Market Analysis

The Pathology Devices Market size is estimated at USD 6.18 billion in 2024, and is expected to reach USD 8.32 billion by 2029, growing at a CAGR of 6.12% during the forecast period (2024-2029).

  • The COVID-19 pandemic had a huge impact on healthcare systems around the world and caused many healthcare facilities to stop providing routine care and pathological testing, putting patients with chronic conditions, including cancer and cardiovascular disorders, at severe risk. For instance, according to an article published in International Medical Journal in January 2022, it was observed that the ratio of the number of pathology tests pre-lockdown and post-lockdown versus baseline period decreased from 1.02 to 0.53, respectively.
  • However, the increased coronavirus cases among the population have increased the demand for pathological tests. For instance, as per an article published in Frontiers in Pathology in March 2022, it was found that the number of molecular microbiology tests was more than three times higher during the lockdown period. This has increased the company's focus on developing innovative pathological test kits and devices. Thus, the studied market is expected to grow and regain its full potential in the coming years.
  • The increasing prevalence and burden of Alzheimer's disease, autoimmune diseases, cancer, and others around the world are driving the need for effective and advanced diagnostic tests, hence propelling the market growth. For instance, according to the 2022 statistics published by Alzheimer's Association, an estimated 6.5 million Americans age 65 and older were living with Alzheimer's dementia in 2022, and this number is projected to reach 13 million by 2050. Thus, the expected increase in the number of people suffering from Alzheimer's disease is anticipated to fuel the demand for pathology devices that helps physicians in early identifying the disease-causing dementia symptoms, thereby propelling the market growth.
  • Additionally, as per the 2023 statistics published by ACS, about 24,810 malignant tumors of the brain or spinal cord (14,280 in males and 10,530 in females) are expected to be diagnosed in the United States in 2023. Thus, the high burden of brain or spinal cord tumors is anticipated to fuel the demand for radionuclide bone scintigraphy (bone scan) for detecting spinal pathologies, hence bolstering the market growth. Moreover, the rising company focus on developing technologically advanced pathological kits and devices is also contributing to the market growth. For instance, in April 2022, Sysmex Europe launched a new three-part differential system, XQ-320 XQ-Series Automated Hematology Analyzer, a robust device that brings excellence in quality to a diverse range of clinical laboratory environments with reliable technology and a new level of usability.
  • Therefore, owing to the factors such as the high burden of chronic and infectious diseases and new product launches, the studied market is expected to grow over the forecast period. However, the high cost of devices and stringent regulations, as well as the lack of skilled professionals, are likely to impede the growth of pathological devices over the forecast period.

Pathology Devices Industry Segmentation

As per the scope of the report, pathology is a branch of medical science that involves the study and diagnosis of disease through the examination of surgically removed organs, tissues (biopsy samples), bodily fluids, and in some cases, the whole body (autopsy). 

The pathology devices market is segmented by technology (clinical chemistry, immunoassays technology, microbiology, molecular diagnostics, and other technologies), application (drug discovery and development, disease diagnostics, forensic diagnostics, and other applications), end-user (pharmaceutical companies, diagnostic laboratories, academic institutes, and other end-users) and geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. 

The report offers the value (in USD million) for the above segments.

By Technology
Clinical Chemistry
Immunoassays Technology
Microbiology
Molecular Diagnostics
Other Technologies
By Application
Drug Discovery and Development
Disease Diagnostics
Forensic Diagnostics
Other Applications
By End-User
Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Pathology Devices Market Size Summary

The pathology devices market is poised for significant growth, driven by the increasing prevalence of chronic and infectious diseases, such as cancer and cardiovascular disorders. The demand for advanced diagnostic tests is on the rise, fueled by the need for early detection and effective management of these conditions. The market is also experiencing a surge in innovation, with companies focusing on developing technologically advanced pathological test kits and devices. This trend is expected to continue, as the healthcare sector recovers from the disruptions caused by the COVID-19 pandemic, which had initially led to a decline in routine pathological testing. The market's expansion is further supported by the growing burden of diseases like Alzheimer's and brain tumors, which necessitate the use of pathology devices for accurate diagnosis and timely intervention.

North America is anticipated to hold a substantial share of the pathology devices market, attributed to its robust healthcare infrastructure and technological advancements in diagnostic devices. The region's increasing incidence of chronic and infectious diseases is driving the demand for early detection and diagnosis, thereby boosting market growth. The proliferation of new product launches in North America is enhancing the availability of advanced diagnostic tools, further propelling the market. The competitive landscape is characterized by the presence of numerous global and local players, who are actively engaging in strategic initiatives such as product launches and collaborations to maintain their market position. As a result, the pathology devices market is expected to witness steady growth over the forecast period, supported by ongoing innovations and increasing demand for precise diagnostic solutions.

Explore More

Pathology Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Chronic and Infectious Diseases

      2. 1.2.2 Technological Advancements in Pathology Devices

      3. 1.2.3 Increasing Investment in Healthcare Infrastructure in Developing Countries

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Devices

      2. 1.3.2 Stringent Regulations and Lack of Skilled Professionals

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Technology

      1. 2.1.1 Clinical Chemistry

      2. 2.1.2 Immunoassays Technology

      3. 2.1.3 Microbiology

      4. 2.1.4 Molecular Diagnostics

      5. 2.1.5 Other Technologies

    2. 2.2 By Application

      1. 2.2.1 Drug Discovery and Development

      2. 2.2.2 Disease Diagnostics

      3. 2.2.3 Forensic Diagnostics

      4. 2.2.4 Other Applications

    3. 2.3 By End-User

      1. 2.3.1 Pharmaceutical Companies

      2. 2.3.2 Hospitals and Diagnostic Laboratories

      3. 2.3.3 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Pathology Devices Market Size FAQs

The Pathology Devices Market size is expected to reach USD 6.18 billion in 2024 and grow at a CAGR of 6.12% to reach USD 8.32 billion by 2029.

In 2024, the Pathology Devices Market size is expected to reach USD 6.18 billion.

Pathology Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)